152 related articles for article (PubMed ID: 19754555)
1. Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches.
Romagnoli S; Milani C; Perin S; Ballabio R; Stelletta C; Mollo A; Gelli D
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():148-51. PubMed ID: 19754555
[TBL] [Abstract][Full Text] [Related]
2. In vivo investigation of luteal function in dogs: effects of cabergoline, a dopamine agonist, and prolactin on progesterone secretion during mid-pregnancy and -diestrus.
Onclin K; Verstegen JP
Domest Anim Endocrinol; 1997 Jan; 14(1):25-38. PubMed ID: 8985667
[TBL] [Abstract][Full Text] [Related]
3. Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
Melis GB; Mais V; Paoletti AM; Beneventi F; Gambacciani M; Fioretti P
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):311-4. PubMed ID: 3279351
[TBL] [Abstract][Full Text] [Related]
4. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
[TBL] [Abstract][Full Text] [Related]
5. Cabergoline inhibits prolactin secretion and accelerates involution in dairy cows after dry-off.
Boutinaud M; Isaka N; Lollivier V; Dessauge F; Gandemer E; Lamberton P; De Prado Taranilla AI; Deflandre A; Sordillo LM
J Dairy Sci; 2016 Jul; 99(7):5707-5718. PubMed ID: 27179868
[TBL] [Abstract][Full Text] [Related]
6. Suppression of prolactin and reduction of milk secretion by effect of cabergoline in lactating dairy ewes.
Caja G; Elhadi A; Such X; Salama AAK
J Dairy Sci; 2020 Dec; 103(12):12033-12044. PubMed ID: 33041043
[TBL] [Abstract][Full Text] [Related]
7. Short communication: The effects of cabergoline administration at dry-off of lactating cows on udder engorgement, milk leakages, and lying behavior.
Bach A; De-Prado A; Aris A
J Dairy Sci; 2015 Oct; 98(10):7097-101. PubMed ID: 26277312
[TBL] [Abstract][Full Text] [Related]
8. [Cabergoline in the inhibition of lactogenesis and suppression of lactopoiesis].
Bracco PL; Armentano G; Pellegrini A; Sugliano GC; Tornatore GP
Minerva Ginecol; 1997 Oct; 49(10):469-73. PubMed ID: 9463181
[TBL] [Abstract][Full Text] [Related]
9. Effects of the dopamine agonist cabergoline on the pulsatile and TRH-induced secretion of prolactin, LH, and testosterone in male beagle dogs.
Koch A; Hoppen HO; Dieleman SJ; Kooistra HS; Günzel-Apel AR
Theriogenology; 2006 May; 65(8):1666-77. PubMed ID: 16289263
[TBL] [Abstract][Full Text] [Related]
10. The effects of a low dose of cabergoline on induction of estrus and pregnancy rates in anestrous bitches.
Cirit U; Bacinoglu S; Cangul IT; Kaya HH; Taş M; Ak K
Anim Reprod Sci; 2007 Sep; 101(1-2):134-44. PubMed ID: 17011145
[TBL] [Abstract][Full Text] [Related]
11. Termination of dioestrus and induction of oestrus in dioestrous nonpregnant bitches by the prolactin antagonist cabergoline.
Jeukenne P; Verstegen J
J Reprod Fertil Suppl; 1997; 51():59-66. PubMed ID: 9404272
[TBL] [Abstract][Full Text] [Related]
12. Effect of stage of anestrus on the induction of estrus by the dopamine agonist cabergoline in dogs.
Verstegen JP; Onclin K; Silva LD; Concannon PW
Theriogenology; 1999 Feb; 51(3):597-611. PubMed ID: 10729045
[TBL] [Abstract][Full Text] [Related]
13. Study of the change of prolactin and progesterone during dopaminergic agonist treatments in pseudopregnant bitches.
Gobello C; de la Sota RL; Goya RG
Anim Reprod Sci; 2001 May; 66(3-4):257-67. PubMed ID: 11348786
[TBL] [Abstract][Full Text] [Related]
14. Oral cabergoline. Single-dose inhibition of puerperal lactation.
Caballero-Gordo A; Lopez-Nazareno N; Calderay M; Caballero JL; Mancheño E; Sghedoni D
J Reprod Med; 1991 Oct; 36(10):717-21. PubMed ID: 1683403
[TBL] [Abstract][Full Text] [Related]
15. Selective control of the estrous cycle of the dog through suppression of estrus and reduction of the length of anestrus.
Phillips TC; Larsen RE; Hernandez J; Strachan L; Samuelson D; Shille VM; Archbald LF
Theriogenology; 2003 Mar; 59(5-6):1441-8. PubMed ID: 12527090
[TBL] [Abstract][Full Text] [Related]
16. Effects on pseudopregnancy, pregnancy and interoestrous intervals of pharmacological suppression of prolactin secretion in female dogs and cats.
Jöchle W; Arbeiter K; Post K; Ballabio R; D'Ver AS
J Reprod Fertil Suppl; 1989; 39():199-207. PubMed ID: 2621723
[TBL] [Abstract][Full Text] [Related]
17. Treatment of lactating sows with the dopamine agonist Cabergoline: effects on LH and prolactin secretion and responses to challenges with naloxone and morphine.
De Rensis F; Quintavalla F; Foxcroft GR
Anim Reprod Sci; 1998 May; 51(3):233-47. PubMed ID: 9675405
[TBL] [Abstract][Full Text] [Related]
18. New developments on the galactopoietic role of prolactin in dairy ruminants.
Lacasse P; Lollivier V; Dessauge F; Bruckmaier RM; Ollier S; Boutinaud M
Domest Anim Endocrinol; 2012 Aug; 43(2):154-60. PubMed ID: 22281117
[TBL] [Abstract][Full Text] [Related]
19. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
[TBL] [Abstract][Full Text] [Related]
20. A study of the aetiology of pseudopregnancy in the bitch and the effect of cabergoline therapy.
Harvey MJ; Dale MJ; Lindley S; Waterston MM
Vet Rec; 1999 Apr; 144(16):433-6. PubMed ID: 10343374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
